The global transport protein assays kits market is expected to witness a market value of US$ 3.36 billion in 2023 and is expected to accumulate a market value of US$ 10.44 billion by registering a CAGR of 12.0% in the forecast period 2023 to 2033. The market for transport protein assays kits registered a CAGR of 5.6% in the historical period 2018 to 2022. Transport proteins function in both active as well as passive transport, in order to move molecules across the plasma membrane. This in turn is expected to boost the growth of Transport protein assays kits market during the forecast period.
As per Future Market Insights - market research and competitive intelligence provider, the global market value for Transport protein assays kits has been escalated, owing to the factors such as increasing occurrence of chronic diseases including cardiac arrests, rise in point-of-care, among others.
The features of Transport protein assays kits such as their fast diagnosis, cost effectiveness, as well as friendly use is one of the major factors that is anticipated to accelerate the growth of the market during the forecast period. In addition, early analysis, drug delivery, among other functions are promising the investors to financially support the biotechnology and pharmaceutical industries. These aforementioned factors are also driving the growth of the Transport protein assays kits market.
Additionally, factors such as the growth in number of healthcare responsiveness programs, increasing government recruits and financial support for the proficient diagnosis of diseases are expected to foster the market growth in the forthcoming years. Also, the emerging applications of transport protein assays kits, coupled with growth in demand for cost vigorous method of clinical operative are also projected to stimulate the market growth in the near future.
Furthermore, factors including the presence of major contributing market players across the globe, rising investment in the field of biotechnology and pharmaceutical, increasing R&D activities, as well as technology development activities are expected to augment the Transport protein assays kits market growth in the coming time.
On the regional end, the Transport protein assays kits market in North America is expected to account for the maximum share during the analysis period, attributed to the factors such as rise in healthcare awareness, advancements in technology, as well as an increase in research and development activities.
On the other hand, European Transport protein assays kits market is expected to hold a significant growth rate over the forecast period, owing to factors such as an increase in urbanization, and an upsurge in healthcare expenditure. Other factors that influence the regional market growth include rise in chronic diseases, and increasing government investments for R&D activities.
Recent developments in the technology, mergers and acquisitions, and partnerships within the companies involved in the development of Transport protein assays kits are expected to create lucrative opportunities for the market growth over the analysis period.
For instance, in July 2021, Ludger launched α1-3,4 Fucosidase enzyme kit [Cat # LZ-FUCOSIDASE-01-KIT] with a unique specificity developed in collaboration with Quadram Institute of Biosciences (Norwich) for the Glycoenzymes for Bioindustries consortium initiative. This exoglycosidase kit consists of α1-3,4 fucosidase enzyme (a recombinant protein derived from intestinal symbiont Ruminococcus gnavus) and a reaction buffer. It is designed for processing up to 50 samples (15 µg glycoprotein or 0.5 µg free glycan each).
Subsequently, in February 2019, Beckman Coulter Life Sciences announced the launch of Apostle MiniMax™ High Efficiency Cell-Free DNA Isolation Kit through an exclusive partnership with Apostle, which is a liquid biopsy company. The Apostle's industry leading chemistry, paired with Beckman Coulter Life Sciences’ portfolio of genomic reagents and liquid handling platforms, enables the researchers to meet the growing demands for sequencing of tumor-derived cfDNA, as cfDNA workflows move beyond theoretical as well as into human health applications.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Transport proteins are proteins that help in transporting of substances across biological membranes. Ions such as sodium and potassium ae the substances transported by transport proteins .They function in both active and passive transport to move molecules across the plasma membrane which is favouring the growth of transport protein assays kits market.
Moreover, facilitated diffusion and active transport are the two transports performed by the transport proteins. Furthermore, these transport proteins are seen in entire human body which include in uptake, distribution and removal of drug including gastrointestinal tract, blood brain barrier, liver, kidney and others which is positively influencing the Transport protein assays kits market growth.
Rising prevalence of chronic diseases which include cardiac arrests, rise in point-of-care, and others are factor positively influencing the Transport protein assays kits market growth. Additionally, transport protein assays kits help in quick diagnosis, cost effectiveness, friendly use, and others are propelling the transport protein assays kits market.
Early diagnosis, drug delivery, and others are encouraging the investors to financial support the biotechnology and pharmaceutical industries which is triggering the Transport protein assays kits growth.
Moreover, presence of major contributing market players and rising investment in the field of biotechnology and pharmaceutical R & D coupled with technology development activities are propelling the Transport protein assays kits market growth in near future.
Furthermore, rise in number of government initiates for the efficient diagnosis of diseases, healthcare awareness programs, financial support and others are encouraging the market growth of Transport protein assays kits. Along with this, emerging applications of transport protein assay kits along with rise in demand for cost effective method of clinical functioning are anticipated to grow the Transport protein assays kits market during the forecast period.
However, low awareness towards the assay kits, low accessibility towards the technology, lack of trained professionals, and stringent regulations are some of the factors hindering the Transport protein assays kits market growth in near future.
Principal Consultant
The global transport protein assay kits market is anticipated to experience vast growth during forecast period. Furthermore, manufacturers are focusing on product line development that is triggering transport protein assays kits for the growth of Transport protein assays kits market in near future.
Based on application the drug delivery and development segment is dominating the Transport protein assays kits market. Based on end user pharmaceutical, biotechnological companies and diagnostics laboratories segments are the fastest growing in the Transport protein assays kits market.
Geographically, the transport protein assay kits market is segmented into North America, Europe, Latin America, South Asia, East Asia, Oceania, Middle East and Africa. North America is dominating the Transport protein assays kits market owing to rise in healthcare awareness, adoption of new technology, rise in research and development activities, and others.
Europe is second largest contributor in the Transport protein assays kits market due to rise in urbanisation, rise in healthcare expenditure and others. Asia Pacific is the fastest growing Transport protein assays kits market owing to rise in geriatric population, rise in chronic diseases, government initiatives for research and development activities and others.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key players contributing the market of transport protein assays kits are Thermo Fisher Scientific Inc., Bio Vision Incorporated, Novus Biologicals, Inc., My BioSource, Merck KGaA, Solvo biotechnology, Abbkine, Inc., KAC CO.Ltd, Molecular devics,LLC and others.
The Transport protein assays test kits market is segmented on the basis of product,application, end users, and region.
Explore Healthcare Insights
View Reports
Transport Protein Assays Kits Market
